Skip to content
Clinical Trials – home
AustriaBack to Austria

Clinical trials in Mattersburg – page 5

55 clinical trials in Mattersburg, Austria. Every trial is listed in the EU Clinical Trials Register and updated daily.

Mattersburg at a glance
55
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

55 trials in Mattersburg

Open in trial search

Colitis ulcerative

Not recruiting

Study on Long-Term Safety and Effectiveness of Upadacitinib for Patients with Ulcerative Colitis

Investigational
Countries:AustriaAustria
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Upadacitinib
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Back pain

Not recruiting

Study on the Effectiveness and Safety of AP707 and Naproxen for Patients with Chronic Back Pain

Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Aceclofenac
  • Sponsor:Apurano Pharmaceuticals GmbH

Pain+1

Not recruiting

Study on the Effectiveness and Safety of AP707 with Lamotrigine and Amitriptyline for Patients with Chronic Central Neuropathic Pain

Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Adezunap
  • Sponsor:Apurano Pharmaceuticals GmbH

Pain+1

Not recruiting

Study on the Effectiveness of AP707, Gabapentin, and Capsaicin for Patients with Chronic Pain from Traumatic or Post-Operative Peripheral Neuropathy

Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Adezunap
  • Sponsor:Apurano Pharmaceuticals GmbH

Diabetic neuropathy+1

Not recruiting

Study on the Effectiveness and Safety of AP707, Amitriptyline, and Capsaicin for Patients with Chronic Pain from Diabetic Neuropathy

Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Adezunap
  • Sponsor:Apurano Pharmaceuticals GmbH

Cardiac failure+1

Not recruiting

Study of AZD3427 for Patients with Heart Failure and Pulmonary Hypertension from Left Heart Disease

Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:AZD3427
  • Sponsor:Astrazeneca AB

Study on Milvexian and Drug Combination for Patients Recovering from a Heart Attack

Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Janssen - Cilag International

Other cities in Austria

The busiest research cities in the country

All 48 cities in Austria

Clinical research in Mattersburg

What the registry says about research in the country

01 Cardiovascular Diseases

In Mattersburg, clinical trial activity in cardiovascular diseases is focused on reducing the risk of serious heart complications and improving long-term outcomes for people with atherosclerotic cardiovascular disease.

  • Studies in atherosclerotic cardiovascular disease and broader cardiovascular disease
  • Research on preventing major heart events and related complications
  • Work aimed at improving treatment effectiveness for high-risk patients

These trials are helping assess whether new therapies can better protect patients from heart attacks, cardiovascular death, and other major events.

02 Nutritional and Metabolic Diseases

Clinical research in nutritional and metabolic diseases in this Austrian city is closely linked to obesity, overweight, and related metabolic risk factors that can affect heart and kidney health.

  • Trials involving obesity and overweight
  • Studies connecting weight-related conditions with cardiovascular disease
  • Research evaluating new approaches to improve metabolic health

The main goal is to understand whether emerging treatments can lower long-term disease burden and support better prevention.

03 Cardiovascular Risk Reduction

Several trials are examining whether investigational therapies can reduce the chance of first or repeat major cardiovascular events in participants with elevated risk factors.

  • Atherosclerotic Cardiovascular Disease and event prevention
  • Elevated Lp(a) as a key risk factor under study
  • Testing new options to reduce heart-related morbidity and mortality

This research focuses on whether better risk control can help prevent heart attacks, urgent procedures, and other serious outcomes.

04 Kidney and Cardiometabolic Health

Some studies also look beyond the heart, examining whether treatments can help preserve kidney function in people with overlapping cardiometabolic conditions.

  • Chronic Kidney Disease in combination with heart risk
  • People living with obesity and related complications
  • Trials exploring whether therapy can support both heart and kidney outcomes

These projects aim to find approaches that address multiple health concerns at once, which is especially important for patients with complex chronic disease.

05 Lipoprotein(a) Research

A notable area of investigation is Lipoprotein(a), or Lp(a), where researchers are testing whether lowering this inherited risk marker can reduce cardiovascular events.

  • Elevated Lp(a) and first major cardiovascular events
  • Studies focused on preventing coronary heart disease and myocardial infarction
  • Evaluating new strategies for people at heightened genetic risk

This work could improve prevention for patients whose heart risk remains high despite standard care.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.